Cargando…

The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis

BACKGROUND: Staphylococcus epidermidis is one of the most multiple resistances to antibiotics in the recent years. Therefore, practically-prescribed antibiotics in the treatment of these strains are not effective. Plant-derived antibacterial is one of the most interesting sources of new therapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales: Siriwong, Supatcharee, Teethaisong, Yothin, Thumanu, Kanjana, Dunkhunthod, Benjawan, Eumkeb, Griangsak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973372/
https://www.ncbi.nlm.nih.gov/pubmed/27491399
http://dx.doi.org/10.1186/s40360-016-0083-8
_version_ 1782446395909734400
author Siriwong, Supatcharee
Teethaisong, Yothin
Thumanu, Kanjana
Dunkhunthod, Benjawan
Eumkeb, Griangsak
author_facet Siriwong, Supatcharee
Teethaisong, Yothin
Thumanu, Kanjana
Dunkhunthod, Benjawan
Eumkeb, Griangsak
author_sort Siriwong, Supatcharee
collection PubMed
description BACKGROUND: Staphylococcus epidermidis is one of the most multiple resistances to antibiotics in the recent years. Therefore, practically-prescribed antibiotics in the treatment of these strains are not effective. Plant-derived antibacterial is one of the most interesting sources of new therapeutics. The present study was to investigate antibacterial, synergy and modes of action of quercetin and amoxicillin against amoxicillin-resistant Staphylococcus epidermidis (ARSE). METHODS: The MICs, checkerboard assay, viability curves, cytoplasmic membrane (CM) permeability, enzyme assay, transmission electron microscopy, confocal microscopy and FT-IR microspectroscopy measurement was performed. RESULTS: The MICs of amoxicillin, penicillin, quercetin and kaempferol against all ARSE strains were 16, 200, 256-384 and >1024 μg/mL respectively. Synergistic effects were exhibited on amoxicillin plus quercetin and penicillin plus kaempferol against these strains at FIC index 0.50 and <0.38 respectively. The synergistic activity of quercetin plus amoxicillin was confirmed by the viable count. This combination increased CM permeability, caused marked morphological, peptidoglycan and cytoplasmic membrane damage, increased protein amide I and II, but decreased fatty acid in bacterial cells. The quercetin had an inhibitory activity against β-lactamase. CONCLUSIONS: So, these findings are the first report that quercetin has the synergistic effect with amoxicillin against ARSE via four modes of actions, inhibit peptidoglycan synthesis and β-lactamases activity, increase CM permeability and protein amide I and II but decrease fatty acid in bacterial cells. Of course, this flavonol has the dominant potential to develop a brand-new collateral phytochemical agent plus amoxicillin to treat ARSE. Future work should focus on the bioavailability, efficacy and toxicity in animal and human studies, as well as, the synergistic effect on blood and tissue should be evaluated and achieved.
format Online
Article
Text
id pubmed-4973372
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49733722016-08-05 The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis Siriwong, Supatcharee Teethaisong, Yothin Thumanu, Kanjana Dunkhunthod, Benjawan Eumkeb, Griangsak BMC Pharmacol Toxicol Research Article BACKGROUND: Staphylococcus epidermidis is one of the most multiple resistances to antibiotics in the recent years. Therefore, practically-prescribed antibiotics in the treatment of these strains are not effective. Plant-derived antibacterial is one of the most interesting sources of new therapeutics. The present study was to investigate antibacterial, synergy and modes of action of quercetin and amoxicillin against amoxicillin-resistant Staphylococcus epidermidis (ARSE). METHODS: The MICs, checkerboard assay, viability curves, cytoplasmic membrane (CM) permeability, enzyme assay, transmission electron microscopy, confocal microscopy and FT-IR microspectroscopy measurement was performed. RESULTS: The MICs of amoxicillin, penicillin, quercetin and kaempferol against all ARSE strains were 16, 200, 256-384 and >1024 μg/mL respectively. Synergistic effects were exhibited on amoxicillin plus quercetin and penicillin plus kaempferol against these strains at FIC index 0.50 and <0.38 respectively. The synergistic activity of quercetin plus amoxicillin was confirmed by the viable count. This combination increased CM permeability, caused marked morphological, peptidoglycan and cytoplasmic membrane damage, increased protein amide I and II, but decreased fatty acid in bacterial cells. The quercetin had an inhibitory activity against β-lactamase. CONCLUSIONS: So, these findings are the first report that quercetin has the synergistic effect with amoxicillin against ARSE via four modes of actions, inhibit peptidoglycan synthesis and β-lactamases activity, increase CM permeability and protein amide I and II but decrease fatty acid in bacterial cells. Of course, this flavonol has the dominant potential to develop a brand-new collateral phytochemical agent plus amoxicillin to treat ARSE. Future work should focus on the bioavailability, efficacy and toxicity in animal and human studies, as well as, the synergistic effect on blood and tissue should be evaluated and achieved. BioMed Central 2016-08-04 /pmc/articles/PMC4973372/ /pubmed/27491399 http://dx.doi.org/10.1186/s40360-016-0083-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Siriwong, Supatcharee
Teethaisong, Yothin
Thumanu, Kanjana
Dunkhunthod, Benjawan
Eumkeb, Griangsak
The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis
title The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis
title_full The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis
title_fullStr The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis
title_full_unstemmed The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis
title_short The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis
title_sort synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant staphylococcus epidermidis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973372/
https://www.ncbi.nlm.nih.gov/pubmed/27491399
http://dx.doi.org/10.1186/s40360-016-0083-8
work_keys_str_mv AT siriwongsupatcharee thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT teethaisongyothin thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT thumanukanjana thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT dunkhunthodbenjawan thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT eumkebgriangsak thesynergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT siriwongsupatcharee synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT teethaisongyothin synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT thumanukanjana synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT dunkhunthodbenjawan synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis
AT eumkebgriangsak synergyandmodeofactionofquercetinplusamoxicillinagainstamoxicillinresistantstaphylococcusepidermidis